NMTRQ-TTG12-1

Across TCGA pan-cancer cohorts, NMTRQ-TTG12-1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated NMTRQ-TTG12-1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher NMTRQ-TTG12-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NMTRQ-TTG12-1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and STAD show a favorable association.

CESC, KIRC, and HNSC are the cancer types where NMTRQ-TTG12-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.127	0.835	<.001	90	view →
KIRC	DFS	Tertile	All	1.000	0.862	.002	84	view →
HNSC	OS	Tertile	II,III,IV	0.001	0.712	<.001	72	view →
LUSC	OS	Tertile	II,III,IV	0.262	0.635	.006	54	view →
CHOL	DFS	Tertile	All	0.116	0.537	.012	42	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	36	view →
ESCA	OS	Median	IV	0.222	0.698	.006	30	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
STAD	DFS	Quartile	II,III,IV	0.743	0.343	.012	9	view →
ACC	OS	Tertile	III,IV	0.189	0.764	.004	9	view →
THCA	DFS	Tertile	IV	0.189	0.839	.001	9	view →
LGG	OS	Tertile	All	0.307	0.453	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

NMTRQ-TTG12-1–CESC (OS)

Open the CESC breakdown →